Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Stage II Prostate Adenocarcinoma × BAY 86-7548 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Stage II Prostate Adenocarcinoma 1

Interventions

prednylidene 1 deltacortene 1 apalutamide 1 Prednisone 1 Magnetic Resonance Spectroscopy 1 Gonadotropin-Releasing Hormone 1 BAY 86-7548 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03113617 2023-12-12

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Stanford University

Phase 2 Completed

44 enrolled 8 charts

Stage II Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡